Advanced Cancer Therapeutics
1 clinical trials · Sponsor
◉ Watch Advanced Cancer Therapeutics
| Record | Firm | Date |
|---|---|---|
| Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies (NCT02044861) | Advanced Cancer Therapeutics | 2014-03-01 |
Track Advanced Cancer Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.